Embecta Corp EMBC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EMBC is a good fit for your portfolio.
News
-
embecta to Report Fiscal Third Quarter 2024 Financial Results
-
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
-
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
-
embecta Announces Quarterly Cash Dividend
-
embecta to Participate in Investor Events
Trading Information
- Previous Close Price
- $15.87
- Day Range
- $15.42–16.09
- 52-Week Range
- $9.93–23.75
- Bid/Ask
- $15.57 / $15.58
- Market Cap
- $897.93 Mil
- Volume/Avg
- 428,768 / 447,724
Key Statistics
- Price/Earnings (Normalized)
- 4.62
- Price/Sales
- 0.81
- Dividend Yield (Trailing)
- 3.85%
- Dividend Yield (Forward)
- 3.85%
- Total Yield
- 3.78%
Company Profile
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,200
- Website
- https://www.embecta.com
Comparables
Valuation
Metric
|
EMBC
|
OM
|
MMSI
|
---|---|---|---|
Price/Earnings (Normalized) | 4.62 | — | 27.25 |
Price/Book Value | — | 2.07 | 4.01 |
Price/Sales | 0.81 | 1.50 | 3.90 |
Price/Cash Flow | 8.30 | — | 21.91 |
Price/Earnings
EMBC
OM
MMSI
Financial Strength
Metric
|
EMBC
|
OM
|
MMSI
|
---|---|---|---|
Quick Ratio | 1.50 | 5.20 | 4.22 |
Current Ratio | 2.29 | 6.42 | 6.03 |
Interest Coverage | 1.45 | −10.39 | 6.17 |
Quick Ratio
EMBC
OM
MMSI
Profitability
Metric
|
EMBC
|
OM
|
MMSI
|
---|---|---|---|
Return on Assets (Normalized) | 12.15% | −38.44% | 9.17% |
Return on Equity (Normalized) | — | −83.38% | 15.14% |
Return on Invested Capital (Normalized) | 28.15% | −43.78% | 10.93% |
Return on Assets
EMBC
OM
MMSI
Medical Instruments & Supplies Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Intuitive Surgical Inc
ISRG
| Btssccpgtm | Ydqyl | $156.8 Bil | |||
Becton Dickinson & Co
BDX
| Rgfrmnlfd | Lgvxqnk | $68.6 Bil | |||
Alcon Inc
ALC
| Tdwnqqb | Hywvx | $46.5 Bil | |||
Coloplast A/S ADR
CLPBY
| Rprbjfpfp | Qfgc | $29.2 Bil | |||
ResMed Inc
RMD
| Xddtdlmfsl | Cmxtjf | $28.9 Bil | |||
West Pharmaceutical Services Inc
WST
| Twdtcxddh | Xlssm | $20.2 Bil | |||
The Cooper Companies Inc
COO
| Vmmhvpzp | Tzmxhh | $18.5 Bil | |||
Hologic Inc
HOLX
| Swyxckcw | Ncqlb | $18.2 Bil | |||
Baxter International Inc
BAX
| Xhdygtsz | Zpwcfjl | $18.1 Bil | |||
Teleflex Inc
TFX
| Brcx | Zlhb | $10.4 Bil |